Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 574

1.

High-resolution array CGH clarifies events occurring on 8p in carcinogenesis.

Cooke SL, Pole JC, Chin SF, Ellis IO, Caldas C, Edwards PA.

BMC Cancer. 2008 Oct 7;8:288. doi: 10.1186/1471-2407-8-288.

2.

High-resolution analysis of chromosome rearrangements on 8p in breast, colon and pancreatic cancer reveals a complex pattern of loss, gain and translocation.

Pole JC, Courtay-Cahen C, Garcia MJ, Blood KA, Cooke SL, Alsop AE, Tse DM, Caldas C, Edwards PA.

Oncogene. 2006 Sep 14;25(41):5693-706. Epub 2006 Apr 24.

PMID:
16636668
3.

LSAMP, a novel candidate tumor suppressor gene in human osteosarcomas, identified by array comparative genomic hybridization.

Kresse SH, Ohnstad HO, Paulsen EB, Bjerkehagen B, Szuhai K, Serra M, Schaefer KL, Myklebost O, Meza-Zepeda LA.

Genes Chromosomes Cancer. 2009 Aug;48(8):679-93. doi: 10.1002/gcc.20675.

PMID:
19441093
4.

Increased copy number at 17q22-q24 by CGH in breast cancer is due to high-level amplification of two separate regions.

Bärlund M, Tirkkonen M, Forozan F, Tanner MM, Kallioniemi O, Kallioniemi A.

Genes Chromosomes Cancer. 1997 Dec;20(4):372-6.

PMID:
9408753
5.

Complex CGH alterations on chromosome arm 8p at candidate tumor suppressor gene loci in breast cancer cell lines.

Venter DJ, Ramus SJ, Hammet FM, de Silva M, Hutchins AM, Petrovic V, Price G, Armes JE.

Cancer Genet Cytogenet. 2005 Jul 15;160(2):134-40.

PMID:
15993269
6.

High-resolution array comparative genomic hybridization of chromosome arm 8q: evaluation of genetic progression markers for prostate cancer.

van Duin M, van Marion R, Vissers K, Watson JE, van Weerden WM, Schröder FH, Hop WC, van der Kwast TH, Collins C, van Dekken H.

Genes Chromosomes Cancer. 2005 Dec;44(4):438-49.

PMID:
16130124
7.

Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines.

Arriola E, Marchio C, Tan DS, Drury SC, Lambros MB, Natrajan R, Rodriguez-Pinilla SM, Mackay A, Tamber N, Fenwick K, Jones C, Dowsett M, Ashworth A, Reis-Filho JS.

Lab Invest. 2008 May;88(5):491-503. doi: 10.1038/labinvest.2008.19. Epub 2008 Mar 10.

8.

Loss of a small region around the PTEN locus is a major chromosome 10 alteration in prostate cancer xenografts and cell lines.

Hermans KG, van Alewijk DC, Veltman JA, van Weerden W, van Kessel AG, Trapman J.

Genes Chromosomes Cancer. 2004 Mar;39(3):171-84.

PMID:
14732919
9.

Deletion at chromosome band 20p12.1 in colorectal cancer revealed by high resolution array comparative genomic hybridization.

Davison EJ, Tarpey PS, Fiegler H, Tomlinson IP, Carter NP.

Genes Chromosomes Cancer. 2005 Dec;44(4):384-91.

PMID:
16110499
10.

Identification of a novel homozygous deletion region at 6q23.1 in medulloblastomas using high-resolution array comparative genomic hybridization analysis.

Hui AB, Takano H, Lo KW, Kuo WL, Lam CN, Tong CY, Chang Q, Gray JW, Ng HK.

Clin Cancer Res. 2005 Jul 1;11(13):4707-16.

11.

Array comparative genomic hybridization analysis of colorectal cancer cell lines and primary carcinomas.

Douglas EJ, Fiegler H, Rowan A, Halford S, Bicknell DC, Bodmer W, Tomlinson IP, Carter NP.

Cancer Res. 2004 Jul 15;64(14):4817-25.

12.

Molecular cytogenetic characterization of pancreas cancer cell lines reveals high complexity chromosomal alterations.

Griffin CA, Morsberger L, Hawkins AL, Haddadin M, Patel A, Ried T, Schrock E, Perlman EJ, Jaffee E.

Cytogenet Genome Res. 2007;118(2-4):148-56. Review.

PMID:
18000365
13.

Integrated analysis of copy number alteration and RNA expression profiles of cancer using a high-resolution whole-genome oligonucleotide array.

Jung SH, Shin SH, Yim SH, Choi HS, Lee SH, Chung YJ.

Exp Mol Med. 2009 Jul 31;41(7):462-70. doi: 10.3858/emm.2009.41.7.051.

14.

Mutation analysis of the 8p candidate tumour suppressor genes DBC2 (RHOBTB2) and LZTS1 in bladder cancer.

Knowles MA, Aveyard JS, Taylor CF, Harnden P, Bass S.

Cancer Lett. 2005 Jul 8;225(1):121-30. Epub 2004 Dec 10.

PMID:
15922864
15.

Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.

Kloth JN, Oosting J, van Wezel T, Szuhai K, Knijnenburg J, Gorter A, Kenter GG, Fleuren GJ, Jordanova ES.

BMC Genomics. 2007 Feb 20;8:53.

16.

Novel candidate tumour suppressor gene loci on chromosomes 11q23-24 and 22q13 involved in human insulinoma tumourigenesis.

Jonkers YM, Claessen SM, Feuth T, van Kessel AG, Ramaekers FC, Veltman JA, Speel EJ.

J Pathol. 2006 Dec;210(4):450-8.

PMID:
17068744
17.

Combined cDNA array comparative genomic hybridization and serial analysis of gene expression analysis of breast tumor progression.

Yao J, Weremowicz S, Feng B, Gentleman RC, Marks JR, Gelman R, Brennan C, Polyak K.

Cancer Res. 2006 Apr 15;66(8):4065-78.

18.

Molecular genetic analysis of chromosome 9 candidate tumor-suppressor loci in bladder cancer cell lines.

Williams SV, Sibley KD, Davies AM, Nishiyama H, Hornigold N, Coulter J, Kennedy WJ, Skilleter A, Habuchi T, Knowles MA.

Genes Chromosomes Cancer. 2002 May;34(1):86-96.

PMID:
11921286
19.

Loss of heterozygosity on the short arm of chromosome 8 in male breast carcinomas.

Chuaqui RF, Sanz-Ortega J, Vocke C, Linehan WM, Sanz-Esponera J, Zhuang Z, Emmert-Buck MR, Merino MJ.

Cancer Res. 1995 Nov 1;55(21):4995-8.

Supplemental Content

Support Center